| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
FUNDAMENTALS OF CANCER MEDICINE |
Correspondence: David S. Goodsell, Ph.D., Associate Professor, The Scripps Research Institute, Department of Molecular Biology, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. Telephone: 858-784-2839; Fax: 858-784-2860; e-mail: goodsell{at}scripps.edu www: http://www.scripps.edu/pub/goodsell
Ponder, for a moment, how unusual it is to be a multicellular organism. Human bodies are composed of ten trillion cells in several hundred varieties. Each cell produces its own energy, builds its own proteins, lives its own tiny life with its own microscopic goals. The only thing that holds us together is the dynamic web of communication between these cells, communication directly by touch and communication remotely through delivery of messages. When any of these messages are fouled, through mutation or by the deliberate commandeering of a rogue virus, the consequences can extend far beyond the life of the affected cell, even threatening the welfare of the entire body.
Oncogenes, in the large part, are sensitive links in our lines of communication. Corruption of these genes, and their products, causes fatal breaches in communication and cooperation between cells. These breaches may be errors in growth factors and cytokines that carry the messages from cell to cell. They may be errors in the receptors that receive the messages, blocking delivery or scrambling the meaning. Or, the fault may lie in enzymes, such as the Src protein, that relay messages inside cells.
Src was first discovered as a hyperactive form carried into cells by Rous sarcoma virus, which rapidly lead to transformation of the cell. The normal form was then found in healthy cells, where it sits at the center of a complex web of cellular communication, taking messages from a variety of cell-surface receptors and passing them on to proteins that control cell differentiation and proliferation.
Src is a biomolecular switch. Normally it is in an inactive state. But, when it finds an activated receptor on the cell surface, it switches "on." Then, it is an efficient protein tyrosine kinase, an enzyme that attaches phosphate groups to tyrosine amino acids in other proteins. The added phosphates, in turn, switch these proteins into the "on" state and they carry the message on to their ultimate targets throughout the cell, stimulating growth.
A clever combination of moving parts controls both the biological and chemical activity. The Src chain includes elements that bind to biological targets, and elements that mimic these targets. To recognize activated receptors, Src looks for polyproline helices with its SH3 domain and it looks for phosphorylated tyrosine residues with its SH2 domain. But most of the time, Src is held in an inactive form (Fig. 1
), with its SH3 domain happily bound to an internal polyproline helix and its SH2 domain securely fastened to the phosphorylated tyrosine on its own tail. The rigidity of this structure, with the SH3 domain pressed tightly to the catalytic domain, firmly shuts the active site. With remarkable molecular parsimony, Src activity is blocked by the same structures that, once released, bind to receptors.
|
|
| ADDITIONAL READING |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C.-H. Li, Q. Zhang, B. Teng, S. J. Mustafa, J.-Y. Huang, and H.-G. Yu Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531 Am J Physiol Cell Physiol, January 1, 2008; 294(1): C355 - C362. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |